Chronopharmacology of glucocorticoids

Hench, 1949, The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report, Ann. Rheum. Dis., 8, 97, 10.1136/ard.8.2.97 Fietta, 2009, Central nervous system effects of natural and synthetic glucocorticoids, Psychiatry Clin. Neurosci., 63, 613, 10.1111/j.1440-1819.2009.02005.x Arlt, 2005, Adrenal corticosteroid biosynthesis, metabolism, and action, Endocrinol. Metab. Clin. N. Am., 34, 293, 10.1016/j.ecl.2005.01.002 Meduri, 2009, Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy, Chest, 136, 1631, 10.1378/chest.08-2408 Elenkov, 2002, Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity, Ann. N. Y. Acad. Sci., 966, 290, 10.1111/j.1749-6632.2002.tb04229.x Liu, 2013, A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy, Allergy, Asthma Clin. Immunol., 9, 30, 10.1186/1710-1492-9-30 Spiga, 2014, HPA axis-rhythms, 1273 Partch, 2014, Molecular architecture of the mammalian circadian clock, Trends Cell Biol., 24, 90, 10.1016/j.tcb.2013.07.002 Gekakis, 1998, Role of the CLOCK protein in the mammalian circadian mechanism, Science, 280, 1564, 10.1126/science.280.5369.1564 Nicolaides, 2017, Stress-related and circadian secretion and target tissue actions of glucocorticoids: impact on health, Front Endocrinol (Lausanne), 8, 70, 10.3389/fendo.2017.00070 Chan, 2010, Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy, Ther. Adv. Endocrinol. Metab., 1, 129, 10.1177/2042018810380214 Spencer, 2018, Glucocorticoid hormones are both a major circadian signal and major stress signal: how this shared signal contributes to a dynamic relationship between the circadian and stress systems, Front. Neuroendocrinol., 49, 52, 10.1016/j.yfrne.2017.12.005 Buijs, 2003, The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system, J. Endocrinol., 177, 17, 10.1677/joe.0.1770017 Oster, 2017, The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids, Endocr. Rev., 38, 3, 10.1210/er.2015-1080 Smith, 2006, The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress, Dialogues Clin. Neurosci., 8, 383, 10.31887/DCNS.2006.8.4/ssmith Sukumaran, 2010, Circadian rhythms in gene expression: relationship to physiology, disease, drug disposition and drug action, Adv. Drug Deliv. Rev., 62, 904, 10.1016/j.addr.2010.05.009 Edwards, 2012, Sixty years after Hench--corticosteroids and chronic inflammatory disease, J. Clin. Endocrinol. Metab., 97, 1443, 10.1210/jc.2011-2879 Kirwan, 2010, Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis, Ann. N. Y. Acad. Sci., 1193, 127, 10.1111/j.1749-6632.2009.05289.x Fisher, 1992, Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm, Clin. Pharmacol. Ther., 51, 677, 10.1038/clpt.1992.80 Beltrametti, 2016, Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review, Ther. Clin. Risk Manag., 12, 1763, 10.2147/TCRM.S112685 Xu, 2008, Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone, AAPS J., 10, 331, 10.1208/s12248-008-9038-3 Curtis, 2006, Population-based assessment of adverse events associated with long-term glucocorticoid use, Arthritis Rheum., 55, 420, 10.1002/art.21984 Rhen, 2005, Antiinflammatory action of glucocorticoids--new mechanisms for old drugs, N. Engl. J. Med., 353, 1711, 10.1056/NEJMra050541 Alten, 2010, Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone, J. Rheumatol., 37, 2025, 10.3899/jrheum.100051 Queckenberg, 2011, Pharmacokinetics, pharmacodynamics, and comparative bioavailability of single, oral 2-mg doses of dexamethasone liquid and tablet formulations: a randomized, controlled, crossover study in healthy adult volunteers, Clin. Ther., 33, 1831, 10.1016/j.clinthera.2011.10.006 Fardet, 2012, Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care, Am. J. Psychiatry, 169, 491, 10.1176/appi.ajp.2011.11071009 Hwang, 2014, Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment, Diabetes Metab. Res. Rev., 30, 96, 10.1002/dmrr.2486 Moghadam-Kia, 2010, Prevention and treatment of systemic glucocorticoid side effects, Int. J. Dermatol., 49, 239, 10.1111/j.1365-4632.2009.04322.x Alangari, 2010, Genomic and non-genomic actions of glucocorticoids in asthma, Ann. Thorac. Med, 5, 133, 10.4103/1817-1737.65040 Buttgereit, 2005, Optimised glucocorticoid therapy: the sharpening of an old spear, Lancet, 365, 801, 10.1016/S0140-6736(05)17989-6 McMaster, 2007, Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects, Exp. Physiol., 92, 299, 10.1113/expphysiol.2006.036194 Fardet, 2014, Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events, Drugs, 74, 1731, 10.1007/s40265-014-0282-9 Straub, 2010, Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases, J. Intern. Med., 267, 543, 10.1111/j.1365-2796.2010.02218.x Cruz-Topete, 2015, One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids, Neuroimmunomodulation, 22, 20, 10.1159/000362724 Yan, 2013, Associations between polymorphisms in the glucocorticoid-receptor gene and cardiovascular risk factors in a Chinese population, J Epidemiol, 23, 389, 10.2188/jea.JE20130035 Dibner, 2010, The mammalian circadian timing system: organization and coordination of central and peripheral clocks, Annu. Rev. Physiol., 72, 517, 10.1146/annurev-physiol-021909-135821 Venneri, 2018, Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study, J. Clin. Endocrinol. Metab., 103, 2998, 10.1210/jc.2018-00346 Potter, 2016, Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures, Endocr. Rev., 37, 584, 10.1210/er.2016-1083 Ohdo, 2010, Chronopharmacological strategies: intra- and inter-individual variability of molecular clock, Adv. Drug Deliv. Rev., 62, 885, 10.1016/j.addr.2010.04.005 Cutolo, 2016, Glucocorticoids and chronotherapy in rheumatoid arthritis, RMD Open, 2, 10.1136/rmdopen-2015-000203 Smolensky, 2007, Chronobiology, drug delivery, and chronotherapeutics, Adv. Drug Deliv. Rev., 59, 828, 10.1016/j.addr.2007.07.001 Ballesta, 2017, Systems chronotherapeutics, Pharmacol. Rev., 69, 161, 10.1124/pr.116.013441 Baraldo, 2008, The influence of circadian rhythms on the kinetics of drugs in humans, Expert Opin. Drug Metab. Toxicol., 4, 175, 10.1517/17425255.4.2.175 Kalsbeek, 2012, Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis, Mol. Cell. Endocrinol., 349, 20, 10.1016/j.mce.2011.06.042 Alderson, 2002, Neurophysiological and clinical aspects of glucocorticoids and memory: a review, J. Clin. Exp. Neuropsychol., 24, 335, 10.1076/jcen.24.3.335.987 Nicolaides, 2015, Stress, the stress system and the role of glucocorticoids, Neuroimmunomodulation, 22, 6, 10.1159/000362736 Charmandari, 2004, Glucocorticoids and their actions: an introduction, Ann. N. Y. Acad. Sci., 1024, 1, 10.1196/annals.1321.001 McEwen, 2010, The role of corticosteroids and stress in chronic pain conditions, Metabolism, 59, S9, 10.1016/j.metabol.2010.07.012 Juster, 2010, Allostatic load biomarkers of chronic stress and impact on health and cognition, Neurosci. Biobehav. Rev., 35, 2, 10.1016/j.neubiorev.2009.10.002 Kalsbeek, 2006, SCN outputs and the hypothalamic balance of life, J. Biol. Rhythm., 21, 458, 10.1177/0748730406293854 Cruz-Topete, 2018, Glucocorticoids: molecular mechanisms of action Oakley, 2013, The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease, J. Allergy Clin. Immunol., 132, 1033, 10.1016/j.jaci.2013.09.007 Hindmarsh, 2015, Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations, Clin. Endocrinol., 82, 557, 10.1111/cen.12653 Beishuizen, 2001, Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma, Intensive Care Med., 27, 1584, 10.1007/s001340101073 Prigent, 2004, Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids, Crit. Care, 8, 243, 10.1186/cc2878 Chapman, 2013, 11beta-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action, Physiol. Rev., 93, 1139, 10.1152/physrev.00020.2012 Joels, 2008, The coming out of the brain mineralocorticoid receptor, Trends Neurosci., 31, 1, 10.1016/j.tins.2007.10.005 Harris, 2013, Mineralocorticoid and glucocorticoid receptor balance in control of HPA axis and behaviour, Psychoneuroendocrinology, 38, 648, 10.1016/j.psyneuen.2012.08.007 Umland, 2002, Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma, Pulm. Pharmacol. Ther., 15, 35, 10.1006/pupt.2001.0312 Charmandari, 2005, Endocrinology of the stress response, Annu. Rev. Physiol., 67, 259, 10.1146/annurev.physiol.67.040403.120816 Spies, 2014, Circadian rhythms in rheumatology--a glucocorticoid perspective, Arthritis Res. Ther., 16, S3, 10.1186/ar4687 Thomson, 2007, Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency, Clin. Endocrinol., 66, 789, 10.1111/j.1365-2265.2007.02812.x Haus, 2007, Chronobiology in the endocrine system, Adv. Drug Deliv. Rev., 59, 985, 10.1016/j.addr.2007.01.001 Kassi, 2013, The central CLOCK system and the stress axis in health and disease, Hormones (Athens), 12, 172, 10.14310/horm.2002.1402 Charmandari, 2014, Adrenal insufficiency, Lancet, 383, 2152, 10.1016/S0140-6736(13)61684-0 Chrousos, 2014, Hypothalamic-pituitary-adrenal axis in HIV infection and disease, Endocrinol. Metab. Clin. N. Am., 43, 791, 10.1016/j.ecl.2014.06.002 Priftis, 2008, The hypothalamic-pituitary-adrenal axis in asthmatic children, Trends Endocrinol. Metab., 19, 32, 10.1016/j.tem.2007.10.005 Chrousos, 2011, Q&A: primary generalized glucocorticoid resistance, BMC Med., 9, 27, 10.1186/1741-7015-9-27 Nicolaides, 2015, Chrousos syndrome: from molecular pathogenesis to therapeutic management, Eur. J. Clin. Investig., 45, 504, 10.1111/eci.12426 Charmandari, 2011, Primary generalized glucocorticoid resistance and hypersensitivity, Horm. Res. Paediatr., 76, 145, 10.1159/000330759 De Iudicibus, 2011, Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease, World J. Gastroenterol., 17, 1095, 10.3748/wjg.v17.i9.1095 Kino, 2001, Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes, J. Endocrinol., 169, 437, 10.1677/joe.0.1690437 Chrousos, 2004, Glucocorticoid action networks--an introduction to systems biology, J. Clin. Endocrinol. Metab., 89, 563, 10.1210/jc.2003-032026 Kino, 2011, Glucocorticoid receptor: implications for rheumatic diseases, Clin. Exp. Rheumatol., 29, S32 Paragliola, 2017, Treatment with synthetic glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis, Int. J. Mol. Sci., 18, 10.3390/ijms18102201 Pujols, 2010, Importance of glucocorticoid receptors in upper and lower airways, Front Biosci. (Landmark Ed), 15, 789, 10.2741/3646 Quax, 2013, Glucocorticoid sensitivity in health and disease, Nat. Rev. Endocrinol., 9, 670, 10.1038/nrendo.2013.183 Chrousos, 2009, Stress and disorders of the stress system, Nat. Rev. Endocrinol., 5, 374, 10.1038/nrendo.2009.106 Mager, 2003, Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation, J. Pharm. Sci., 92, 1521, 10.1002/jps.10402 Pereira, 2017, Glucocorticoid regulation of neurocognitive and neuropsychiatric function Franchimont, 2002, Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference, Neuroimmunomodulation, 10, 247, 10.1159/000069969 Chrousos, 2009, Glucocorticoid signaling in the cell. expanding clinical implications to complex human behavioral and somatic disorders, Ann. N. Y. Acad. Sci., 1179, 153, 10.1111/j.1749-6632.2009.04988.x Lee, 2014, Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity, Biochim. Biophys. Acta, 1842, 473, 10.1016/j.bbadis.2013.05.029 Wang, 2015, Glucocorticoid receptors in the locus coeruleus mediate sleep disorders caused by repeated corticosterone treatment, Sci. Rep., 5, 9442, 10.1038/srep09442 Czock, 2005, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids, Clin. Pharmacokinet., 44, 61, 10.2165/00003088-200544010-00003 Schacke, 2004, Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects, Proc. Natl. Acad. Sci. U. S. A., 101, 227, 10.1073/pnas.0300372101 Strehl, 2013, Optimized glucocorticoid therapy: teaching old drugs new tricks, Mol. Cell. Endocrinol., 380, 32, 10.1016/j.mce.2013.01.026 Mager, 2003, Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics, J. Clin. Pharmacol., 43, 1216, 10.1177/0091270003258651 Hydrocortisone, in: L.A. Anderson (Ed.), 2017. Melin, 2018, Predicting cortisol exposure from paediatric hydrocortisone formulation using a semi-mechanistic pharmacokinetic model established in healthy adults, Clin. Pharmacokinet., 57, 515, 10.1007/s40262-017-0575-8 Debono, 2009, Modified-release hydrocortisone to provide circadian cortisol profiles, J. Clin. Endocrinol. Metab., 94, 1548, 10.1210/jc.2008-2380 Prednisone, in: L.A. Anderson (Ed.). Methylprednisolone, in: L.A. Anderson (Ed.). Chow, 1999, Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone, J. Pharmacokinet. Biopharm., 27, 559, 10.1023/A:1020974408657 Xu, 2007, A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma, J. Pharmacokinet. Pharmacodyn., 34, 355, 10.1007/s10928-007-9050-8 de Kloet, 2007, Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder, Psychoneuroendocrinology, 32, 215, 10.1016/j.psyneuen.2006.12.009 Dexamethasone, in: L.A. Anderson (Ed.). Newell-Price, 2008, Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers, Clin. Endocrinol., 68, 130, 10.1111/j.1365-2265.2007.03011.x Findling, 2004, The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome, J. Clin. Endocrinol. Metab., 89, 1222, 10.1210/jc.2003-030207 Plenadren Annex I: Summary of product characteristics, Eur. Med. Agency. Vogt, 2007, Biowaiver monographs for immediate release solid oral dosage forms: prednisolone, J. Pharm. Sci., 96, 27, 10.1002/jps.20768 Vogt, 2007, Biowaiver monographs for immediate release solid oral dosage forms: prednisone, J. Pharm. Sci., 96, 1480, 10.1002/jps.20817 Lindenberg, 2004, Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the biopharmaceutics classification system, Eur. J. Pharm. Biopharm., 58, 265, 10.1016/j.ejpb.2004.03.001 Ploger, 2018, Solubility determination of active pharmaceutical ingredients which have been recently added to the list of essential medicines in the context of the biopharmaceutics classification system-biowaiver, J. Pharm. Sci., 107, 1478, 10.1016/j.xphs.2018.01.025 Magee, 2001, Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race, J. Clin. Pharmacol., 41, 1180, 10.1177/00912700122012733 Meno-Tetang, 2001, Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women, J. Clin. Pharmacol., 41, 1195, 10.1177/00912700122012742 Lew, 1993, Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics, Clin. Pharmacol. Ther., 54, 402, 10.1038/clpt.1993.167 Ohdo, 2011, Molecular basis of chronopharmaceutics, J. Pharm. Sci., 100, 3560, 10.1002/jps.22656 Griffett, 2013, The mammalian clock and chronopharmacology, Bioorg. Med. Chem. Lett., 23, 1929, 10.1016/j.bmcl.2013.02.015 Binkhorst, 2015, Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients, Breast Cancer Res. Treat., 152, 119, 10.1007/s10549-015-3452-x Dallmann, 2016, Dosing-time makes the poison: circadian regulation and pharmacotherapy, Trends Mol. Med., 22, 430, 10.1016/j.molmed.2016.03.004 Rao, 2016, Mathematical modeling of the circadian dynamics of the neuroendocrine-immune network in experimentally induced arthritis, Am. J. Physiol. Endocrinol. Metab., 158, 4017 Ovacik, 2010, Circadian signatures in rat liver: from gene expression to pathways, BMC Bioinformatics, 11, 540, 10.1186/1471-2105-11-540 Almon, 2008, Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle, Am. J. Phys. Regul. Integr. Comp. Phys., 295, R1031 Almon, 2008, Circadian variations in rat liver gene expression: relationships to drug actions, J. Pharmacol. Exp. Ther., 326, 700, 10.1124/jpet.108.140186 Mavroudis, 2015, Circadian characteristics of permissive and suppressive effects of cortisol and their role in homeostasis and the acute inflammatory response, Math. Biosci., 260, 54, 10.1016/j.mbs.2014.10.006 Mavroudis, 2013, Systems biology of circadian-immune interactions, J. Innate. Immun., 5, 153, 10.1159/000342427 Mavroudis, 2012, Entrainment of peripheral clock genes by cortisol, Physiol. Genomics, 44, 607, 10.1152/physiolgenomics.00001.2012 Mavroudis, 2014, Mathematical modeling of light-mediated HPA axis activity and downstream implications on the entrainment of peripheral clock genes, Physiol. Genomics, 46, 766, 10.1152/physiolgenomics.00026.2014 Kirwan, 2011, Targeting the time of day for glucocorticoid delivery in rheumatoid arthritis, Int. J. Clin. Rheumatol., 6, 273, 10.2217/ijr.11.23 Haus, 2012, Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications, Bull. NYU Hosp. J. Dis., 70, 3 Cutolo, 2008, Circadian rhythms in arthritis: hormonal effects on the immune/inflammatory reaction, Autoimmun. Rev., 7, 223, 10.1016/j.autrev.2007.11.019 Kino, 2012, Circadian rhythms of glucocorticoid hormone actions in target tissues: potential clinical implications, Sci. Signal., 5, pt4, 10.1126/scisignal.2003333 Ravindran, 2016, Modified-release prednisone in rheumatoid arthritis: rationale for chronotherapy, mechanistic considerations, and clinical implications, Indian J. Rheumatol., 11, 216, 10.4103/0973-3698.192680 Ohdo, 2003, Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety, Drug Saf., 26, 999, 10.2165/00002018-200326140-00002 Burioka, 2010, Asthma: chronopharmacotherapy and the molecular clock, Adv. Drug Deliv. Rev., 62, 946, 10.1016/j.addr.2010.03.012 Sundar, 2015, Circadian molecular clock in lung pathophysiology, Am. J. Phys. Lung Cell. Mol. Phys., 309, L1056 Alavoine, 2015, Nocturnal asthma: proof-of-concept open-label study with delayed-release prednisone, Pulm. Ther., 1, 43, 10.1007/s41030-015-0001-z Durrington, 2014, Recent advances in chronotherapy for the management of asthma, ChronoPhysiology Ther., 125 Truong, 2016, Timing matters: circadian rhythm in Sepsis, obstructive lung disease, obstructive sleep apnea, and cancer, Ann. Am. Thorac. Soc., 13, 1144, 10.1513/AnnalsATS.201602-125FR Smolensky, 2001, Circadian rhythms and clinical medicine with applications to hypertension, Am. J. Hypertens., 14, 280S, 10.1016/S0895-7061(01)02175-6 Glass-Marmor, 2007, Chronotherapy using corticosteroids for multiple sclerosis relapses, J. Neurol. Neurosurg. Psychiatry, 78, 886, 10.1136/jnnp.2006.104000 Pierre, 2016, The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity, Physiol. Genomics, 48, 719, 10.1152/physiolgenomics.00006.2016 Sajan, 2009, Chronotherapeutics and chronotherapeutic drug delivery systems, Trop. J. Pharm. Res., 8, 467, 10.4314/tjpr.v8i5.48091 Lemmer, 1999, Chronopharmacokinetics: implications for drug treatment, J. Pharm. Pharmacol., 51, 887, 10.1211/0022357991773294 Levi, 2007, Circadian rhythms: mechanisms and therapeutic implications, Annu. Rev. Pharmacol. Toxicol., 47, 593, 10.1146/annurev.pharmtox.47.120505.105208 Lemmer, 2012, The importance of biological rhythms in drug treatment of hypertension and sex-dependent modifications, ChronoPhysiology and Ther., 9 Erkekoglu, 2012, Chronopharmacokinetics of drugs in toxicological aspects: a short review for pharmacy practitioners, J. Res. Pharm. Pract., 1, 3, 10.4103/2279-042X.108369 Sukumaran, 2010, Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology, Physiol. Genomics, 42A, 141, 10.1152/physiolgenomics.00106.2010 Kostewicz, 2014, PBPK models for the prediction of in vivo performance of oral dosage forms, Eur. J. Pharm. Sci., 57, 300, 10.1016/j.ejps.2013.09.008 McAllister, 1981, Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects, Br. J. Clin. Pharmacol., 11, 303, 10.1111/j.1365-2125.1981.tb00538.x Lamiable, 1991, Chronopharmacokinetics of dexamethasone in young subjects, Therapie, 46, 405 Musiek, 2013, Molecular clocks in pharmacology, Handb. Exp. Pharmacol., 243, 10.1007/978-3-642-25950-0_10 Gupta, 2013, Chronopharmacology: an overview, J. Ration. pharmacother. Res., 1, 6 Adil, 2014, Chronoterapuetics: targeting the disease at its ideal time, Pharma Innov. J., 2 Chapman, 2016, Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information, Clin. Endocrinol., 84, 664, 10.1111/cen.12991 Alten, 2015, Hypothalamic-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with different glucocorticoid approaches, Neuroimmunomodulation, 22, 83, 10.1159/000362731 Hayasaka, 2007, Optimization of dosing schedule of daily inhalant dexamethasone to minimize phase shifting of clock gene expression rhythm in the lungs of the asthma mouse model, Endocrinology, 148, 3316, 10.1210/en.2007-0010 Behan, 2011, Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients, Clin. Endocrinol., 75, 505, 10.1111/j.1365-2265.2011.04074.x Naafs, 2018, Glucocorticoid chronotherapy: a mini-review, Endocrinol. Metab. Int. J., 6, 118 Debono, 2009, Novel strategies for hydrocortisone replacement, Best Pract. Res. Clin. Endocrinol. Metab., 23, 221, 10.1016/j.beem.2008.09.010 Debono, 2009, Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy, Eur. J. Endocrinol., 160, 719, 10.1530/EJE-08-0874 Isidori, 2018, Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial, Lancet Diabetes Endocrinol., 6, 173, 10.1016/S2213-8587(17)30398-4 Cutolo, 2015, Circadian use of glucocorticoids in rheumatoid arthritis, Neuroimmunomodulation, 22, 33, 10.1159/000362733 Chung, 2016, Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrations, Clin. Endocrinol., 84, 496, 10.1111/cen.12982 Debono, 2013, What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?, Clin. Endocrinol., 78, 659, 10.1111/cen.12117 Rao, 2018, Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis, Chronobiol. Int., 1 Burt, 2011, Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD, J. Clin. Endocrinol. Metab., 96, 1789, 10.1210/jc.2010-2729 Prigent, 2004, Clinical review: corticotherapy in sepsis, Crit. Care, 8, 122, 10.1186/cc2374 Seibel, 2013, Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives, Lancet Diabetes Endocrinol., 1, 59, 10.1016/S2213-8587(13)70045-7 Rogers, 2017, Osteoporotic fractures in men study research, rest-activity circadian rhythms and bone mineral density in elderly men, Bone Rep, 7, 156, 10.1016/j.bonr.2017.11.001 Hartmanshenn, 2016, Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine, J. Pharmacokinet. Pharmacodyn., 43, 481, 10.1007/s10928-016-9492-y Rao, 2017, Modeling the sex differences and Interindividual variability in the activity of the hypothalamic-pituitary-adrenal Axis, Endocrinology, 158, 4017, 10.1210/en.2017-00544 Ebner, 2017, Individual differences in stress susceptibility and stress inhibitory mechanisms, Curr. Opin. Behav. Sci., 14, 54, 10.1016/j.cobeha.2016.11.016 Cutolo, 2005, Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms, Autoimmun. Rev., 4, 497, 10.1016/j.autrev.2005.04.019 Kouri, 2013, Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level, PLoS ONE, 8, 10.1371/journal.pone.0054049 Chrousos, 2010, Stress and sex versus immunity and inflammation, Sci. Signal., 3, 10.1126/scisignal.3143pe36 Yehuda, 2002, The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder, Biol. Psychiatry, 52, 393, 10.1016/S0006-3223(02)01357-4 Dallmann, 2014, Chronopharmacology: new insights and therapeutic implications, Annu. Rev. Pharmacol. Toxicol., 54, 339, 10.1146/annurev-pharmtox-011613-135923 Song, 2017, Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment, Pharmacogenomics, 18, 293, 10.2217/pgs-2016-0151 Ibrahim, 2017, The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational study, Ther. Adv. Gastroenterol., 10, 829, 10.1177/1756283X17730748 Pujolsa, 2009, Glucocorticoid receptor in human respiratory epithelial cells, Neuroimmunomodulation, 16, 290, 10.1159/000216187 Oakley, 2011, Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids, J. Biol. Chem., 286, 3177, 10.1074/jbc.R110.179325 Crown, 2005, Why is the management of glucocorticoid deficiency still controversial: a review of the literature, Clin. Endocrinol., 63, 483, 10.1111/j.1365-2265.2005.02320.x